AI powered early diagnostics for neurodegenerative diseases
some facts
Every 3 seconds 1 person develops
dementia in the world.
No cure
There is no cure yet.
1.4T EUR
Health expense in high income countries on dementia by 2050.
25%
Faulty diagnosis. 50% gets no diagnose at all.
131.5M
People with dementia by 2030
10M
People with Parkinson’s Disease
We practice deep medicine
Or how Artificial Intelligence can
help
tackle neurodegeneration.
In conjunction with increasingly advanced computational approaches, a wide spectrum of neurodegenerative disease models, data-driven or knowledge-driven, have been developed. We want to capture biomedical data to detect neurodegenerative diseases (like Alzheimer’s, Parkinson’s disease) 15-20 years before the symptoms show. AI powered diagnostics and therapies to offer a longer health span.
Neurodegenerative diseases
Neurodegeneration is the progressive loss of structure and/or function of neurons, including death of neurons.
Such diseases are incurable. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances.
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Other neurodegenerative diseases
We practice deep medicine. Solving
healthcare issues with artificial intelligence.
We introduce early non-invasive diagnostics of neurodegenerative
diseases among adults aged 45 and up by affordable and an AI powered
mobile application using digital biomarkers.
01
Noninvasive technology cuts costs & allows for broader diagnostics
02
Innovative high quality data capturing allows for early detection
03
Digital biomarkers predict disease development where invasive methods fail
04
AI-powered solution that improves with every additional test
OUR TECHNOLOGY
Intellectual Property
High Quality Data Capture Solution
The core technology of
Deep Diagnostics.
Neuro digital Biomarkers & AI Algorithms
The core technology of Deep Diagnostics.
Micro & Macro facial expression detection
Measuring the quality of life and well-being of people with dementia or other neurodegenerative diseases.
Contact us to Learn More
About our Process
Neurodegeneration is the progressive loss of structure and/or
function of neurons, including death of neurons.
OUR TARGET SEGMENT
All people 45 years and up
We target healthy people of 45 years and older; people that have
early signs of dementia; or have been diagnosed with a neurodegenerative disease.
People that want to maintain
a healthy lifestyle
People with early signs of
dementia
diagnosed with a neurodegenerative disease
PROGRESS
Our Journey
A team of data & medical scientists have researched & developed
this solution over the last 4 years.
2019
Start of research & development on Deep Diagnose
2020
First release test version of Deep Diagnose application
2021-2022
Deep Diagnose CE certification Testing
2023
Release to market
Services
We provide a
diagnostics
& therapy
solution.
features
- Patient App
- Dashboard Doctor
- Patient Record
- Unlimited tests
features
- Patient App
- Dashboard Doctor
- Patient Record
- Neurotraining
- Gamma therapy
Our Products
We target healthy people of 45 years and older; people that have
early signs of dementia; or have been diagnosed with a neurodegenerative disease.
Deep Diagnose
We researched the available neurocognitive tests and pre-selected the methods that could provide us with additional input (digital biomarkers based on eye-tracking, micro-expressions, hand-eye coordination, and natural speech) about the neurocognitive health of the test taker.
The tasks we selected are scored and the user’s reaction times (time to respond to the tasks) are recorded in order to define possible differences amongst healthy and non-healthy individuals.
- Digital neurocognitive status monitoring
- Constant analysis
- Post-diagnose therapies
- Automatic calibration in real-time
- In/output to medical specialist
- Noninvasive, not expensive
- Early & accurate diagnose
- 100% secure and GDPR compliant
Deep Therapy
- Digital neurocognitive status monitoring
- Constant analysis
- Therapy
- Gamified & easy to use
- In/output to medical specialist
- Noninvasive, not expensive
- Disease evolution is slowed down
HOW IT WORKS
The Business Model
PHASE 1: Deep Diagnose
- Doctor prescribes application to suspecting patients and all people 45 years and older.
- Patient uses test module to establish a diagnosis.
- Yearly fee per patient – refunded by health insurance.
- Feedback from neurologist with validation of diagnosis.
PHASE 2: Deep Therapy
- Neurologist prescribes our application as monitoring tool to patient.
- Patient uses monitoring module to maintain control of disease.
- Monthly subscription fee – refunded by health insurance.
- Periodic appointment with specialist for feedback.
About us
Our Growing Team
Dr. Hendrik Schwagten, PhD
Head of Medical Research
Tom De Bast, MSc
Chief Marketing
Officer
James Troch, MSc
Chief Executive
Officer
Annemiek Van Hese, MSc
Chief Executive
Officer
Timothy de Leeuw, BSc
Product Manager
Prof. Dr. Patrick Wessa, PhD
Head of AI Research
Dr. Salza Palpurina, PhD
Head Data Science
Dr. Iordan Hristov, PhD
Head Data Science
drs. Ivan Arshinkov, MSc
Head Data Science
Research & Development team
Head of Medical Research
Advisory board
Hospitals and Specialists
GET IN TOUCH
AI powered early diagnostics for neurodegenerative diseases
Deep Medicine
hello@deepmedicine.io
deepmedicine.io